Ching-Hsuan Hu1, Yi-Wen Tseng1, Chien-Wei Lee2, Chih-Yung Chiou3, Shiow-Shuh Chuang4, Jui-Yung Yang4, Oscar K Lee5. 1. Department of Plastic and Reconstructive Surgery, Chang Gung Memorial Hospital, Chang Gung Medical College and Chang Gung University, Taoyuan, Taiwan; Institute of Clinical Medicine, and Stem cell Research Center, National Yang-Ming University,Taipei, Taiwan; Stem Cell Research Center, National Yang-Ming University, Taipei, Taiwan. 2. Institute for Tissue Engineering and Regenerative Medicine, The Chinese University of Hong Kong; School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong. 3. Institute of Clinical Medicine, and Stem cell Research Center, National Yang-Ming University,Taipei, Taiwan. 4. Department of Plastic and Reconstructive Surgery, Chang Gung Memorial Hospital, Chang Gung Medical College and Chang Gung University, Taoyuan, Taiwan. 5. Institute of Clinical Medicine, and Stem cell Research Center, National Yang-Ming University,Taipei, Taiwan; Stem Cell Research Center, National Yang-Ming University, Taipei, Taiwan. Electronic address: oscar.lee@cuhk.edu.hk.
Abstract
BACKGROUND: Both mesenchymal stem cell-conditioned medium (MSC CM) and Botox have demonstrated therapeutic effects for hypertrophic scar (HS). It is unclear whether a synergistic effect occurs when these treatments are used in combination. We aimed to investigate the therapeutic effects of MSC CM and Botox alone when compared with those of a combined regimen on HS. METHODS: Fibroblasts from human HS were isolated and treated with Dulbecco's modified Eagle's medium (DMEM), MSCCM, or Botox alone or a combination of MSCCM and Botox. We also used an in vivo HS-buried null mice model to investigate the efficacy of combination treatment. RESULTS: The results demonstrated that the combination of MSC CM and Botox downregulated both mRNA and protein levels of type I collagen, type III collagen, and alpha-smooth muscle actin (α-SMA) in HS fibroblasts. The combined regimen also suppressed fibroblast proliferative activity, increased apoptosis, and displayed significant inhibitory effects on the contractile ability of HS fibroblasts compared to MSC CM, Botox, or DMEM alone. Using an in vivo HS-buried null mice model, significant scar weight reduction, cell apoptosis, and less α-SMA expression were observed from the combined regimen of MSC CM and Botox compared to those from the other groups. The combined regimen also significantly improved arrangement and deposition of collagen fibers. CONCLUSIONS: This study demonstrates that a combination of MSC CM and Botox exhibited a significant therapeutic effect compared to monotherapy. Clinical translation of this therapy should be further considered.
BACKGROUND: Both mesenchymal stem cell-conditioned medium (MSC CM) and Botox have demonstrated therapeutic effects for hypertrophic scar (HS). It is unclear whether a synergistic effect occurs when these treatments are used in combination. We aimed to investigate the therapeutic effects of MSC CM and Botox alone when compared with those of a combined regimen on HS. METHODS: Fibroblasts from human HS were isolated and treated with Dulbecco's modified Eagle's medium (DMEM), MSCCM, or Botox alone or a combination of MSCCM and Botox. We also used an in vivo HS-buried null mice model to investigate the efficacy of combination treatment. RESULTS: The results demonstrated that the combination of MSC CM and Botox downregulated both mRNA and protein levels of type I collagen, type III collagen, and alpha-smooth muscle actin (α-SMA) in HS fibroblasts. The combined regimen also suppressed fibroblast proliferative activity, increased apoptosis, and displayed significant inhibitory effects on the contractile ability of HS fibroblasts compared to MSC CM, Botox, or DMEM alone. Using an in vivo HS-buried null mice model, significant scar weight reduction, cell apoptosis, and less α-SMA expression were observed from the combined regimen of MSC CM and Botox compared to those from the other groups. The combined regimen also significantly improved arrangement and deposition of collagen fibers. CONCLUSIONS: This study demonstrates that a combination of MSC CM and Botox exhibited a significant therapeutic effect compared to monotherapy. Clinical translation of this therapy should be further considered.
Authors: Chien-Wei Lee; Yi-Fan Chen; Allen Wei-Ting Hsiao; Amanda Yu-Fan Wang; Oscar Yuan-Jie Shen; Belle Yu-Hsuan Wang; Lok Wai Cola Ho; Wei-Ting Lin; Chung Hang Jonathan Choi; Oscar Kuang-Sheng Lee Journal: J Adv Res Date: 2021-11-19 Impact factor: 12.822
Authors: Christine Bojanic; Kendrick To; Adam Hatoum; Jessie Shea; K T Matthew Seah; Wasim Khan; Charles M Malata Journal: Cell Tissue Res Date: 2021-01-02 Impact factor: 5.249
Authors: Giuseppe Cottone; Francesco Amendola; Carlo Strada; Maria Chiara Bagnato; Roberto Brambilla; Francesco De Francesco; Luca Vaienti Journal: Medicina (Kaunas) Date: 2021-12-15 Impact factor: 2.430